Okuda M
Japan Allergy and Asthma Clinic, Nippon Medical School, 1-1 Sendagi, Bunkyoku, Tokyo, Japan.
Curr Allergy Asthma Rep. 2001 May;1(3):235-41. doi: 10.1007/s11882-001-0010-x.
Grading the severity of rhinitis symptoms is essential for the evaluation of drug efficacy. However, a uniform grading system has not been standardized. A review of 44 journal articles and symposia from Japan, Copenhagen, and the World Health Organization indicates major differences among systems. All except the World Health Organization used a sum of rhinitis scores. The lack of standardization limits comparisons of subjective symptom changes after comparable treatments. Corrective measures include the use of evidence-based definitions of independent nasal symptoms, avoidance of biases in evaluation, and establishment of international consensus for a standardized scale in this era of globalization.
对鼻炎症状的严重程度进行分级对于评估药物疗效至关重要。然而,尚未标准化统一的分级系统。对来自日本、哥本哈根和世界卫生组织的44篇期刊文章和研讨会的综述表明,各系统之间存在重大差异。除世界卫生组织外,其他所有系统都采用了鼻炎评分总和。缺乏标准化限制了在可比治疗后主观症状变化的比较。纠正措施包括使用基于证据的独立鼻部症状定义、避免评估中的偏差以及在全球化时代就标准化量表达成国际共识。